Nasdaq vktx.

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine analysts that are presently covering the …The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023. The analyst firm set a price target ...Viking Therapeutics (NASDAQ:VKTX) - Although it is a small-cap biotech firm Viking Therapeutics is a company that is involved in an interesting niche. It is involved in treating endocrine and metabolic disorders. At this point in time, ...Fiscal Q3 2023 ended 9/30/23. Reported on 10/25/23. Get the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to …May 13, 2021 · So we'll take a look at whether insiders have been buying or selling shares in Viking Therapeutics, Inc. (NASDAQ:VKTX). ... NasdaqCM:VKTX Insider Trading Volume May 13th 2021.

9 brokers have issued 1 year target prices for Viking Therapeutics' shares. Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price.Viking Therapeutics, Inc. (NASDAQ:VKTX)’s largest hedge fund investor is Andreas Halvorsen’s Viking Global through a stake worth $57.4 million. 9. Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Viking Therapeutics (NASDAQ:VKTX) Lifted to Sell at StockNews.com marketbeat.com - August 24 at 1:17 AM: 5 Best Weight Loss Stocks To Invest In insidermonkey.com - August 22 at 5:54 PM: E Fund Management Co. Ltd. Invests $511,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX) marketbeat.com - August 22 at 9:24 AMClinical-stage biotech Viking Therapeutics ( VKTX 6.23%) is having another tough trading session. As of 1:40 p.m. ET Tuesday, Viking's stock was down by 19.8% on higher-than-normal volume ...

SAN DIEGO, March 28, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...SAN DIEGO, Oct. 17, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...Strong Quarter-End Cash Position of $376M. SAN DIEGO, Oct. 25, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the ...Today's Change. (1.85%) $0.21. Current Price. $11.56. Price as of November 22, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium ...VKTXNASDAQ 12.28USD +0.72 +6.23% At close at Nov 24, 13:58 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast VKTX chart Today 6.23% 5 days 16.40% 1 month 15.20% 6 months …

So, the natural question for Viking Therapeutics (NASDAQ:VKTX) shareholders is whether they should be concerned by its rate of cash burn. In this report, ...

Mar. 28, 2023, 08:37 AM. Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of ...

Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. Metabolic and rare disease programs include novel selective thyroid... VKTX : 12.28 (+6.23%) Viking Therapeutics to Participate at Upcoming Investor Conferences PR Newswire - Thu Sep 7, 3:05PM CDT.LL28. The last time I spoke about Viking Therapeutics, Inc. (NASDAQ:VKTX), I talked about its progress in advancing its drug VK2809 for the treatment of patients with non-alcoholic steatohepatitis ...Viking Therapeutics said VK2809 met the main goal of a phase 2b trial by showing statistically significant reductions in liver fat in patients with NASH. VKTX +12% yesterday, @CR144 Research ...Standing squarely in the bull camp, BTIG analyst Justin Zelin rates VKTX a Buy along with a $20 price target. This target puts the upside potential at a whopping 221%. (To watch Zelin’s track ...Nov 26, 2023 · Strong Quarter-End Cash Position of $376M. SAN DIEGO, Oct. 25, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the ...

06 Jan, 2021, 16:05 ET. SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel ...We believe that if VK2809 Ph2b biopsy-confirmed NASH trial outcome is sufficient to continue into Ph3 development, then we see VKTX’s current market cap as …Viking Therapeutics, Inc. (NASDAQ:VKTX) is a San Diego, California-based biotech company developing therapeutics for patients that are suffering from endocrine and metabolic disorders.Standing squarely in the bull camp, BTIG analyst Justin Zelin rates VKTX a Buy along with a $20 price target. This target puts the upside potential at a whopping 221%. (To watch Zelin’s track ...Analyst's Opinion · Consensus Rating. Viking Therapeutics has received a consensus rating of Buy. · Price Target Upside/Downside. According to analysts' ...

Viking Therapeutics, Inc. VKTX NASDAQ.

Mar 29, 2023 · Viking Therapeutics (VKTX 4.42%), a small-cap biotech, has been on quite the ride over the past few months.Thanks to a positive late-stage trial in nonalcoholic steatohepatitis (NASH) from rival ... VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 55% based on the firm’s underlying fundamentals and the stock ...Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine analysts that are presently covering the stock, MarketBeat Ratings reports.Nine analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have covered …Viking Therapeutics, Inc. (NASDAQ:VKTX) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose 8.7%, resulting in a US$167m rise in the company's market ...VKTX VKTX AFTER HOURS QUOTE VKTX LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ... Shares of Viking Therapeutics VKTX have surged almost 70% on Mar 28, after it announced positive clinical data of VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose ...Find the latest Viking Therapeutics, Inc. (VKTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Indeed, Viking Therapeutics (NASDAQ:VKTX) stock is up 246% in the last year, providing strong gains for shareholders. Nonetheless, only a fool would ignore the risk that a loss making company ...Roth Capital reduced its price target to $15 from $20 in April 2022, outlining changes to its financial model. Sio Capital’s Q4 2021 stake in Viking Therapeutics, Inc. (NASDAQ:VKTX) was worth $3 ...According to 11 analysts, the average rating for VKTX stock is "Strong Buy." The 12-month stock price forecast is $29.36, which is an increase of 90.03% from ...

Nov 30, 2023 · The latest price target for . Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023.The analyst firm set a price target for 32.00 expecting VKTX to rise ...

Viking Therapeutics Earnings & Revenue FAQ. What were VKTX's earnings last quarter? On Oct 25, 2023, Viking Therapeutics (NASDAQ: VKTX) reported Q3 2023 ...

Viking Therapeutics, Inc. (VKTX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Viking Therapeutics, ...Simply Wall St ™. Simply Wall Street Pty Ltd. Level 7, 320 Pitt Street, Sydney. Popular Markets. US AU UK IN CA ZA. About Us Careers. Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927).Nov 21, 2023 · VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 55% based on the firm’s underlying fundamentals and the stock ... Viking Therapeutics, Inc. (NASDAQ:VKTX) is developing treatments for liver diseases, post surgical complications, and other ailments. Despite a hefty short interest percentage, ...Benzinga. Nov. 14, 2023, 11:42 AM. Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b study of VK2809. What To Know ...Find the latest Insider Activity data for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.(NASDAQ: VKTX) Viking Therapeutics's 52-week high was $25.72, and its 52-week low was $3.54. It is currently -49.42% from its 52-week high and 267.51% from its ...SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...Jan 24, 2022 · What happenedInvestors didn't exactly launch a raid on Viking Therapeutics (NASDAQ: VKTX) stock during Monday's trading session. The shares tumbled by nearly 7% on the back of discouraging news ... VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.VKTX U.S.: Nasdaq Viking Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:47 p.m. EST Delayed quote $ 13.10 0.09 0.69% After …Viking Therapeutics, Inc. Common Stock (VKTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

SAN DIEGO, Sept. 9, 2020 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...Dec 1, 2023 · In the previous quarter, Viking Therapeutics (NASDAQ:VKTX) missed the analysts' consensus estimate of ($0.22) by $0.01 with a reported earnings per share (EPS) of ($0.23). Learn more on analysts' earnings estimate vs. VKTX's actual earnings. Viking Therapeutics Inc stock price live 13.010, this page displays NASDAQ VKTX stock exchange data. View the VKTX premarket stock price ahead of the market session or assess the after hours quote.About Latest Pre-Market Trades. Nasdaq provides market information opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. See Also. Nasdaq MarketSIte. Do Not Sell …Instagram:https://instagram. handyman coursescyclical stock listmarket trading hoursfuture prop firms Viking Therapeutics, Inc. (VKTX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Viking Therapeutics, ...As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq. do you need insurance for chiropractordoes trupanion cover x rays Nov 21, 2023 · VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 55% based on the firm’s underlying fundamentals and the stock ... View Premium Services. Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis. nyse ms compare Jan 3, 2023 · Rasi Bhadramani. Viking Therapeutics (NASDAQ:VKTX) has been my top NASH stock for the past few years due to VK2809's performance, the company's cash position, and the reasonable valuation ... Dec 15, 2019 · Of the funds tracked by Insider Monkey, Peter S. Park's Park West Asset Management has the largest position in Viking Therapeutics, Inc. (NASDAQ:VKTX), worth close to $12 million, accounting for 0 ... Viking Therapeutics (NASDAQ:VKTX) - Although it is a small-cap biotech firm Viking Therapeutics is a company that is involved in an interesting niche. It is involved in treating endocrine and metabolic disorders. At this point in time, ...